Podcast: Enhancing the role of multiplexing in HTS

The latest sponsored DDW Sitting Down With podcast features Paul Wylie, Director of Multiplex at Abcam looking at enhancing the role of multiplexing in high-throughput screening. 

Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and how high-throughput screening can help alleviate this. High throughput with multiplex is valuable for drug discovery and Wylie will provide insight on this as well offering expert opinion on the future of multiplex immunoassays in drug and biomarker discovery. 

Tune in to hear what critical factors Wylie believes researchers should consider when choosing an assay for high-throughput screening, as well as to gain a greater understanding robustness and assay reproducibility. Wylie both outlines the challenges in this field of drug discovery and suggests ways in which these challenges can be overcome.  

Listen now 

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free